OrbusNeich Medical Group Holdings Limited (HK:6929) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OrbusNeich Medical Group Holdings Limited is scheduled to hold a Board meeting on August 16, 2024, to discuss and potentially approve the interim financial results for the first half of the year, consider declaring an interim dividend, and conduct other business matters. The announcement was made by the company’s Chairman, Executive Director, and CEO, Mr. David CHIEN. The current Board includes a mix of Executive, Non-Executive, and Independent Non-executive Directors.
For further insights into HK:6929 stock, check out TipRanks’ Stock Analysis page.